Zuellig delivers Moderna vaccine for Covid, in time for Songkran
Zuellig Pharma has delivered the first lot of 376,320 Moderna vaccines to Chulabhorn Royal Academy on Tuesday.
Sunaiyanaa Kidkasetpaisal, general manager of ZP Therapeutics, Zuellig Pharma Thailand, said on Wednesday that the company was glad to join hands with the academy for citizens to be able to get Moderna vaccines, especially during the Songkran festival.
The increasing number of Omicron patients has suddenly raised worries about the variant.
Recently, the New England Journal of Medicine reported a comparative study in Qatar on the effectiveness of Moderna and Pfizer vaccines in preventing Covid-19.
The study evaluated the number of patients who had received two doses of Moderna and Pfizer from December 21, 2020, to October 20, 2021.
According to the study, only 878 Covid cases were reported from 192,123 people who had receive two doses of the Moderna vaccine. Only three had severe symptoms that required hospitalisation but there were no fatalities or patients in a critical condition.
In comparison, 1,262 Covid cases were reported from 192,123 people who had received two doses of the Pfizer vaccine. Seven of them had severe symptoms and one of them died.
The study concluded that the infection rate after receiving the Moderna vaccine is lower than the Pfizer vaccine, which is in line with previous studies.
“ZP Therapeutics is determined to increase vaccine accessibility to citizens and support Thailand to deal with Covid-19 by presenting world-class services to hospitals with distribution, digital service, and commercial, to support Thailand’s Covid-19 vaccination guidelines,” Sunaiyanaa said.
She added that the company is focused on creating protection for variants of concern during the Songkran festival.